QRxPharma Ltd - Strategic SWOT Analysis Review

November 2021 | 19 pages | ID: Q23C3465BDCEN
GlobalData

Abstracts

QRxPharma Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early-stage clinical drug candidates. QRxPharma’s dual opioid product portfolio includes Moxduo IR (Q8003), an immediate-release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company’s abuse-deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

QRxPharma Ltd - Key Facts
QRxPharma Ltd - Key Employees
QRxPharma Ltd - Major Products and Services
QRxPharma Ltd - History
QRxPharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
QRxPharma Ltd - Business Description
QRxPharma Ltd - Corporate Strategy
QRxPharma Ltd - SWOT Analysis
SWOT Analysis - Overview
QRxPharma Ltd - Strengths
QRxPharma Ltd - Weaknesses
QRxPharma Ltd - Opportunities
QRxPharma Ltd - Threats
QRxPharma Ltd - Key Competitors

SECTION 3 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

QRxPharma Ltd, Key Facts
QRxPharma Ltd, Key Employees
QRxPharma Ltd, Major Products and Services
QRxPharma Ltd, History
QRxPharma Ltd, Subsidiaries
QRxPharma Ltd, Joint Venture
QRxPharma Ltd, Key Competitors